Get the Stockscreener App
23.90
0.87%
-0.21
Regencell Bioscience Holdings Ltd stock is traded at $23.90, with a volume of 69,813.
It is down -0.87% in the last 24 hours and down -17.44% over the past month.
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.
See More
Previous Close:
$24.11
Open:
$24.18
24h Volume:
69,813
Relative Volume:
0.54
Market Cap:
$11.82B
Revenue:
-
Net Income/Loss:
$-7.05M
P/E Ratio:
-1,683.10
EPS:
-0.0142
Net Cash Flow:
$-767.30K
1W Performance:
-7.36%
1M Performance:
-17.44%
6M Performance:
+107.29%
1Y Performance:
-96.77%
1-Day Range:
$23.71
$24.43
1-Week Range:
$23.09
$27.50
52-Week Range:
$9.39
$950.00
Regencell Bioscience Holdings Ltd Stock (RGC) Company Profile
Compare RGC vs TAK, TEVA, HLN, ZTS, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RGC
Regencell Bioscience Holdings Ltd
|
23.90 | 11.92B | 0 | -7.05M | -767.30K | -0.0142 |
TAK
Takeda Pharmaceutical Co Adr
|
15.96 | 51.03B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
35.32 | 40.20B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.06 | 40.78B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
77.69 | 32.81B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
556.82 | 23.86B | 3.17B | 1.29B | 1.01B | 27.09 |
Regencell Bioscience Holdings Ltd Stock (RGC) Latest News
Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Regencell Bioscience Holdings Limited and Encourages Investors to Contact the Firm Before June 23rd - GlobeNewswire Inc.
RGC INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Regencell Bioscience Holdings Ltd. Shareholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
SueWallSt Reminds Regencell Bioscience Holdings Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of June 23, 2026RGC - Barchart.com
RGC SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Regencell Bioscience Holdings Ltd. Investors Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Regencell (RGC) director exits 70,600 options in issuer buyback - Stock Titan
Regencell Bioscience Holdings Limited (RGC) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - Barchart.com
RGC INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Regencell Bioscience Holdings Ltd. Investors Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
RGC Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Regencell Bioscience Holdings Limited Securities LawsuitContact The Gross Law Firm - Barchart.com
RGC INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announce - The National Law Review
RGC SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Annou - The National Law Review
Regencell Bioscience Holdings (RGC) Stock Analysis: Is This Hong Kong Healthcare Player Set for a Breakthrough? - DirectorsTalk Interviews
Bronstein, Gewirtz & Grossman LLC Urges Regencell - GlobeNewswire
What Are the Core Allegations Against Regencell Bioscience - Kavout
RGC INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Regencell Bioscience Holdings Ltd. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Regencell (RGC) raises $20M in registered direct stock offering - Stock Titan
RGC INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Regencell Bioscience Holdings Ltd. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Regencell - GlobeNewswire
A Look At Regencell Bioscience Holdings (RGC) Valuation After Lawsuits And DOJ Trading Investigation - simplywall.st
Lead Plaintiff Deadlines in Shareholder Class Action - GlobeNewswire
RGC INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Regencell Bioscience Holdings Ltd. Stockholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Regencell Bioscience (NASDAQ: RGC) sells 985,222 shares at $20.30 - Stock Titan
Regencell Bioscience announces $20 million direct offering of ordinary shares - Investing.com
Regencell Bioscience (RGC) to raise about $20M in registered direct share sale - Stock Titan
Regencell (Nasdaq: RGC) prices $20M registered direct offering - Stock Titan
RGC Shareholder Alert: Regencell Bioscience Holdings Limited Securities Class Action LawsuitInvestors With Losses May Contact The Gross Law Firm - Barchart.com
RGC Investors Have Opportunity to Lead Regencell Bioscience Holdings Limited Securities Fraud Lawsuit - Barchart
Bronstein, Gewirtz & Grossman LLC Urges Regencell Bioscience Holdings Ltd. Investors to Act: Class Action Filed Alleging Investor Harm - Carroll County Mirror-Democrat
How Investors May Respond To Regencell Bioscience Holdings (RGC) Widening Half-Year Net Loss And Per-Share Deficit - simplywall.st
RGC UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Regencell Bioscience (RGC) Investors of Securities Class Action Deadline on June 23, 2026 - PR Newswire
VinFast, Alcoa, and Regencell are among the top 10 large-cap gainers last week (March 30-April 2): Are the others in your portfolio? - MSN
Pomerantz Law Firm Announces the Filing of a Class Action Against Regencell Bioscience Holdings Limited and Certain OfficersRGC - PR Newswire
RGC INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Regencell Bioscience Holdings Ltd. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Bragar Eagel & Squire, P.C. Reminds Investors that a Class - GlobeNewswire
TradingKey - TradingKey
RGC INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Regencell Bioscience Holdings Ltd. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
RGC STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Annou - The National Law Review
RGC Deadline Alert: The Gross Law Firm Reminds Regencell Bioscience Holdings Limited (RGC) Investors of Securities Class Action Deadline on June 23, 2026 - Barchart.com
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Regencell Bioscience Holdings Limited Investors to Secure Counsel Before Important Deadline in Securities Class ActionRGC - TMX Newsfile
Regencell Bioscience Holdings (RGC) Stock Analysis: Navigating a $14.48 Billion Market Cap Amidst Undefined Financial Metrics - DirectorsTalk Interviews
RGC SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Regencell Bioscience Holdings Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
A Look At Regencell Bioscience Holdings (RGC) Valuation After DOJ Probe And Class Action Lawsuits - Sahm
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Regencell Bioscience Holdings Limited Investors to Secure Counsel Before Important Deadline in Securities Class Action – RGC - Scott Coop
Best Chinese Stocks To Follow TodayMay 9th - MarketBeat
[6-K] Regencell Bioscience Holdings Ltd Current Report (Foreign Issuer) | RGC SEC FilingForm 6-K - Stock Titan
Regencell Bioscience (NASDAQ:RGC) Trading Down 9%What's Next? - MarketBeat
RGC INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Regencell Bioscience Holdings Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
RGC Shareholder Alert: Regencell Bioscience Holdings - GlobeNewswire
Regencell Bioscience (NASDAQ:RGC) Trading 11.1% HigherTime to Buy? - MarketBeat
RGC INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Regencell Bioscience Holdings Ltd. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Regencell Bioscience Holdings Ltd Stock (RGC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.54%
0.81%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):